nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Docetaxel—head and neck cancer	0.0996	0.537	CbGbCtD
Argatroban—Gangrene—Hydroxyurea—head and neck cancer	0.0705	0.0918	CcSEcCtD
Argatroban—CYP3A4—Vinblastine—head and neck cancer	0.0471	0.254	CbGbCtD
Argatroban—CYP3A4—Docetaxel—head and neck cancer	0.0388	0.209	CbGbCtD
Argatroban—Angina unstable—Docetaxel—head and neck cancer	0.0316	0.0412	CcSEcCtD
Argatroban—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0248	0.0322	CcSEcCtD
Argatroban—Digestion impaired—Hydroxyurea—head and neck cancer	0.023	0.03	CcSEcCtD
Argatroban—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0224	0.0291	CcSEcCtD
Argatroban—Bullous eruption—Docetaxel—head and neck cancer	0.0202	0.0263	CcSEcCtD
Argatroban—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0138	0.0179	CcSEcCtD
Argatroban—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0137	0.0178	CcSEcCtD
Argatroban—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0125	0.0163	CcSEcCtD
Argatroban—Renal failure acute—Hydroxyurea—head and neck cancer	0.0121	0.0158	CcSEcCtD
Argatroban—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0117	0.0152	CcSEcCtD
Argatroban—Pleural effusion—Docetaxel—head and neck cancer	0.0104	0.0136	CcSEcCtD
Argatroban—Angina pectoris—Vinblastine—head and neck cancer	0.0103	0.0134	CcSEcCtD
Argatroban—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00994	0.0129	CcSEcCtD
Argatroban—Sepsis—Fluorouracil—head and neck cancer	0.00961	0.0125	CcSEcCtD
Argatroban—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0093	0.0121	CcSEcCtD
Argatroban—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00929	0.0121	CcSEcCtD
Argatroban—Myocardial infarction—Vinblastine—head and neck cancer	0.00925	0.012	CcSEcCtD
Argatroban—Haemoglobin—Vinblastine—head and neck cancer	0.00852	0.0111	CcSEcCtD
Argatroban—Haemorrhage—Vinblastine—head and neck cancer	0.00847	0.011	CcSEcCtD
Argatroban—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00841	0.011	CcSEcCtD
Argatroban—Cardiac failure—Fluorouracil—head and neck cancer	0.00824	0.0107	CcSEcCtD
Argatroban—Respiratory failure—Docetaxel—head and neck cancer	0.00814	0.0106	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00804	0.0105	CcSEcCtD
Argatroban—Pulmonary embolism—Docetaxel—head and neck cancer	0.00799	0.0104	CcSEcCtD
Argatroban—Haemoglobin—Hydroxyurea—head and neck cancer	0.00777	0.0101	CcSEcCtD
Argatroban—Haemorrhage—Hydroxyurea—head and neck cancer	0.00773	0.0101	CcSEcCtD
Argatroban—Cardiac arrest—Fluorouracil—head and neck cancer	0.00764	0.00995	CcSEcCtD
Argatroban—Pulmonary oedema—Docetaxel—head and neck cancer	0.00712	0.00926	CcSEcCtD
Argatroban—Angiopathy—Hydroxyurea—head and neck cancer	0.00701	0.00913	CcSEcCtD
Argatroban—Sepsis—Docetaxel—head and neck cancer	0.00694	0.00903	CcSEcCtD
Argatroban—Angina pectoris—Fluorouracil—head and neck cancer	0.00677	0.00881	CcSEcCtD
Argatroban—Thrombophlebitis—Docetaxel—head and neck cancer	0.0067	0.00873	CcSEcCtD
Argatroban—Pneumonia—Fluorouracil—head and neck cancer	0.00623	0.00811	CcSEcCtD
Argatroban—Atrial fibrillation—Docetaxel—head and neck cancer	0.00612	0.00797	CcSEcCtD
Argatroban—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00611	0.00795	CcSEcCtD
Argatroban—Renal impairment—Docetaxel—head and neck cancer	0.0061	0.00794	CcSEcCtD
Argatroban—Myocardial infarction—Fluorouracil—head and neck cancer	0.00607	0.00791	CcSEcCtD
Argatroban—Dermatitis bullous—Docetaxel—head and neck cancer	0.00607	0.0079	CcSEcCtD
Argatroban—Urinary tract infection—Fluorouracil—head and neck cancer	0.00602	0.00784	CcSEcCtD
Argatroban—Cardiac failure—Docetaxel—head and neck cancer	0.00595	0.00774	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.0058	0.00756	CcSEcCtD
Argatroban—Haemoglobin—Fluorouracil—head and neck cancer	0.00559	0.00728	CcSEcCtD
Argatroban—Haemorrhage—Fluorouracil—head and neck cancer	0.00556	0.00724	CcSEcCtD
Argatroban—Infection—Hydroxyurea—head and neck cancer	0.00545	0.0071	CcSEcCtD
Argatroban—Pain—Vinblastine—head and neck cancer	0.00515	0.0067	CcSEcCtD
Argatroban—Constipation—Vinblastine—head and neck cancer	0.00515	0.0067	CcSEcCtD
Argatroban—Feeling abnormal—Vinblastine—head and neck cancer	0.00496	0.00646	CcSEcCtD
Argatroban—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00492	0.00641	CcSEcCtD
Argatroban—Dyspnoea—Hydroxyurea—head and neck cancer	0.00489	0.00637	CcSEcCtD
Argatroban—Angina pectoris—Docetaxel—head and neck cancer	0.00489	0.00636	CcSEcCtD
Argatroban—Dyspepsia—Hydroxyurea—head and neck cancer	0.00483	0.00629	CcSEcCtD
Argatroban—Abdominal pain—Vinblastine—head and neck cancer	0.00476	0.0062	CcSEcCtD
Argatroban—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00474	0.00617	CcSEcCtD
Argatroban—Pain—Hydroxyurea—head and neck cancer	0.00469	0.00611	CcSEcCtD
Argatroban—Constipation—Hydroxyurea—head and neck cancer	0.00469	0.00611	CcSEcCtD
Argatroban—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00452	0.00589	CcSEcCtD
Argatroban—Pneumonia—Docetaxel—head and neck cancer	0.0045	0.00586	CcSEcCtD
Argatroban—Hypersensitivity—Vinblastine—head and neck cancer	0.00444	0.00577	CcSEcCtD
Argatroban—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00441	0.00574	CcSEcCtD
Argatroban—Myocardial infarction—Docetaxel—head and neck cancer	0.00438	0.00571	CcSEcCtD
Argatroban—Body temperature increased—Hydroxyurea—head and neck cancer	0.00434	0.00565	CcSEcCtD
Argatroban—Chest pain—Fluorouracil—head and neck cancer	0.00412	0.00537	CcSEcCtD
Argatroban—Diarrhoea—Vinblastine—head and neck cancer	0.00412	0.00536	CcSEcCtD
Argatroban—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00404	0.00527	CcSEcCtD
Argatroban—Haemoglobin—Docetaxel—head and neck cancer	0.00403	0.00525	CcSEcCtD
Argatroban—Haemorrhage—Docetaxel—head and neck cancer	0.00401	0.00523	CcSEcCtD
Argatroban—Confusional state—Fluorouracil—head and neck cancer	0.00398	0.00519	CcSEcCtD
Argatroban—Dizziness—Vinblastine—head and neck cancer	0.00398	0.00518	CcSEcCtD
Argatroban—Infection—Fluorouracil—head and neck cancer	0.00393	0.00511	CcSEcCtD
Argatroban—Tachycardia—Fluorouracil—head and neck cancer	0.00386	0.00502	CcSEcCtD
Argatroban—Vomiting—Vinblastine—head and neck cancer	0.00383	0.00498	CcSEcCtD
Argatroban—Headache—Vinblastine—head and neck cancer	0.00377	0.00491	CcSEcCtD
Argatroban—Diarrhoea—Hydroxyurea—head and neck cancer	0.00376	0.00489	CcSEcCtD
Argatroban—Hypotension—Fluorouracil—head and neck cancer	0.00369	0.00481	CcSEcCtD
Argatroban—Angiopathy—Docetaxel—head and neck cancer	0.00364	0.00474	CcSEcCtD
Argatroban—Dizziness—Hydroxyurea—head and neck cancer	0.00363	0.00473	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.0036	0.0778	CbGpPWpGaD
Argatroban—Nausea—Vinblastine—head and neck cancer	0.00358	0.00466	CcSEcCtD
Argatroban—Dyspnoea—Fluorouracil—head and neck cancer	0.00352	0.00459	CcSEcCtD
Argatroban—Vomiting—Hydroxyurea—head and neck cancer	0.00349	0.00454	CcSEcCtD
Argatroban—Dyspepsia—Fluorouracil—head and neck cancer	0.00348	0.00453	CcSEcCtD
Argatroban—Rash—Hydroxyurea—head and neck cancer	0.00346	0.00451	CcSEcCtD
Argatroban—Dermatitis—Hydroxyurea—head and neck cancer	0.00346	0.0045	CcSEcCtD
Argatroban—Headache—Hydroxyurea—head and neck cancer	0.00344	0.00448	CcSEcCtD
Argatroban—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00341	0.00444	CcSEcCtD
Argatroban—Back pain—Docetaxel—head and neck cancer	0.00338	0.0044	CcSEcCtD
Argatroban—Pain—Fluorouracil—head and neck cancer	0.00338	0.0044	CcSEcCtD
Argatroban—Nausea—Hydroxyurea—head and neck cancer	0.00326	0.00425	CcSEcCtD
Argatroban—Feeling abnormal—Fluorouracil—head and neck cancer	0.00326	0.00424	CcSEcCtD
Argatroban—Body temperature increased—Fluorouracil—head and neck cancer	0.00312	0.00407	CcSEcCtD
Argatroban—Cough—Docetaxel—head and neck cancer	0.00305	0.00397	CcSEcCtD
Argatroban—Chest pain—Docetaxel—head and neck cancer	0.00298	0.00387	CcSEcCtD
Argatroban—Hypersensitivity—Fluorouracil—head and neck cancer	0.00291	0.00379	CcSEcCtD
Argatroban—Confusional state—Docetaxel—head and neck cancer	0.00288	0.00374	CcSEcCtD
Argatroban—Infection—Docetaxel—head and neck cancer	0.00283	0.00369	CcSEcCtD
Argatroban—Tachycardia—Docetaxel—head and neck cancer	0.00278	0.00362	CcSEcCtD
Argatroban—Diarrhoea—Fluorouracil—head and neck cancer	0.0027	0.00352	CcSEcCtD
Argatroban—Hypotension—Docetaxel—head and neck cancer	0.00267	0.00347	CcSEcCtD
Argatroban—Dizziness—Fluorouracil—head and neck cancer	0.00261	0.0034	CcSEcCtD
Argatroban—Dyspnoea—Docetaxel—head and neck cancer	0.00254	0.00331	CcSEcCtD
Argatroban—Vomiting—Fluorouracil—head and neck cancer	0.00251	0.00327	CcSEcCtD
Argatroban—Dyspepsia—Docetaxel—head and neck cancer	0.00251	0.00327	CcSEcCtD
Argatroban—Rash—Fluorouracil—head and neck cancer	0.00249	0.00324	CcSEcCtD
Argatroban—Dermatitis—Fluorouracil—head and neck cancer	0.00249	0.00324	CcSEcCtD
Argatroban—Headache—Fluorouracil—head and neck cancer	0.00248	0.00322	CcSEcCtD
Argatroban—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00246	0.00321	CcSEcCtD
Argatroban—Constipation—Docetaxel—head and neck cancer	0.00244	0.00318	CcSEcCtD
Argatroban—Pain—Docetaxel—head and neck cancer	0.00244	0.00318	CcSEcCtD
Argatroban—Feeling abnormal—Docetaxel—head and neck cancer	0.00235	0.00306	CcSEcCtD
Argatroban—Nausea—Fluorouracil—head and neck cancer	0.00235	0.00306	CcSEcCtD
Argatroban—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00233	0.00304	CcSEcCtD
Argatroban—Abdominal pain—Docetaxel—head and neck cancer	0.00225	0.00294	CcSEcCtD
Argatroban—Body temperature increased—Docetaxel—head and neck cancer	0.00225	0.00294	CcSEcCtD
Argatroban—Hypersensitivity—Docetaxel—head and neck cancer	0.0021	0.00274	CcSEcCtD
Argatroban—Diarrhoea—Docetaxel—head and neck cancer	0.00195	0.00254	CcSEcCtD
Argatroban—Dizziness—Docetaxel—head and neck cancer	0.00189	0.00246	CcSEcCtD
Argatroban—Vomiting—Docetaxel—head and neck cancer	0.00181	0.00236	CcSEcCtD
Argatroban—Rash—Docetaxel—head and neck cancer	0.0018	0.00234	CcSEcCtD
Argatroban—Dermatitis—Docetaxel—head and neck cancer	0.0018	0.00234	CcSEcCtD
Argatroban—Headache—Docetaxel—head and neck cancer	0.00179	0.00233	CcSEcCtD
Argatroban—Nausea—Docetaxel—head and neck cancer	0.00169	0.00221	CcSEcCtD
Argatroban—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00141	0.0305	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00135	0.0291	CbGpPWpGaD
Argatroban—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.00124	0.0268	CbGpPWpGaD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00119	0.0258	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—KISS1—head and neck cancer	0.00113	0.0244	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.00112	0.0241	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—SOD2—head and neck cancer	0.0011	0.0237	CbGpPWpGaD
Argatroban—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00109	0.0236	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—GPX1—head and neck cancer	0.00105	0.0226	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00101	0.0219	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—GRP—head and neck cancer	0.000932	0.0201	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00092	0.0199	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000872	0.0188	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—PIK3CA—head and neck cancer	0.000852	0.0184	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000834	0.018	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000832	0.018	CbGpPWpGaD
Argatroban—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK3—head and neck cancer	0.00082	0.0177	CbGpPWpGaD
Argatroban—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—head and neck cancer	0.00078	0.0168	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00075	0.0162	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000737	0.0159	CbGpPWpGaD
Argatroban—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00069	0.0149	CbGpPWpGaD
Argatroban—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000662	0.0143	CbGpPWpGaD
Argatroban—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000628	0.0136	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000617	0.0133	CbGpPWpGaD
Argatroban—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000577	0.0125	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.000574	0.0124	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—head and neck cancer	0.000571	0.0123	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—KISS1—head and neck cancer	0.000571	0.0123	CbGpPWpGaD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000555	0.012	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.000546	0.0118	CbGpPWpGaD
Argatroban—F2—PAR1-mediated thrombin signaling events—PIK3CA—head and neck cancer	0.000534	0.0115	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000515	0.0111	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000509	0.011	CbGpPWpGaD
Argatroban—F2—Platelet Aggregation (Plug Formation)—AKT1—head and neck cancer	0.000492	0.0106	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00049	0.0106	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000474	0.0102	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.000474	0.0102	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GRP—head and neck cancer	0.00047	0.0102	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000468	0.0101	CbGpPWpGaD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000429	0.00926	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000418	0.00903	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.000387	0.00836	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—head and neck cancer	0.000367	0.00793	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—GRP—head and neck cancer	0.000331	0.00714	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—KISS1—head and neck cancer	0.000323	0.00697	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000296	0.0064	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KISS1—head and neck cancer	0.000293	0.00633	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—head and neck cancer	0.000274	0.00592	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GRP—head and neck cancer	0.000266	0.00574	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—HRAS—head and neck cancer	0.000254	0.00548	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GRP—head and neck cancer	0.000241	0.00521	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00024	0.00518	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	0.000239	0.00517	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000236	0.00511	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000234	0.00506	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000231	0.00499	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	0.000228	0.00492	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	0.000228	0.00492	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000222	0.00479	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00022	0.00476	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000219	0.00473	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000217	0.0047	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000217	0.00469	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	0.000198	0.00427	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—UROD—head and neck cancer	0.000195	0.00422	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000194	0.0042	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.000185	0.00399	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000179	0.00386	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000175	0.00377	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KISS1—head and neck cancer	0.000173	0.00374	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00017	0.00367	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00017	0.00367	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.000166	0.00359	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000165	0.00356	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000147	0.00319	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000144	0.00312	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRP—head and neck cancer	0.000142	0.00308	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT6—head and neck cancer	0.000138	0.00299	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000136	0.00295	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—YAP1—head and neck cancer	0.000122	0.00264	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000118	0.00255	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—head and neck cancer	0.000112	0.00242	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000109	0.00235	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000107	0.00232	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000103	0.00223	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000102	0.0022	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—head and neck cancer	9.52e-05	0.00206	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—UROD—head and neck cancer	9.08e-05	0.00196	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK3—head and neck cancer	9e-05	0.00195	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAPK1—head and neck cancer	8.57e-05	0.00185	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NAT2—head and neck cancer	8.11e-05	0.00175	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—head and neck cancer	7.43e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—head and neck cancer	7.19e-05	0.00155	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DPYD—head and neck cancer	7.11e-05	0.00154	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—head and neck cancer	7.08e-05	0.00153	CbGpPWpGaD
Argatroban—F2—Hemostasis—HRAS—head and neck cancer	6.88e-05	0.00149	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—YAP1—head and neck cancer	6.75e-05	0.00146	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—head and neck cancer	6.43e-05	0.00139	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—head and neck cancer	6.07e-05	0.00131	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH1—head and neck cancer	5.52e-05	0.00119	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK3—head and neck cancer	5.17e-05	0.00112	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MAPK1—head and neck cancer	4.92e-05	0.00106	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—head and neck cancer	4.92e-05	0.00106	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—head and neck cancer	4.7e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—head and neck cancer	4.27e-05	0.000922	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TYMS—head and neck cancer	4.05e-05	0.000875	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—head and neck cancer	4e-05	0.000865	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRAS—head and neck cancer	3.95e-05	0.000853	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—head and neck cancer	3.84e-05	0.000829	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—head and neck cancer	3.83e-05	0.000828	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—head and neck cancer	3.8e-05	0.00082	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP1A1—head and neck cancer	3.8e-05	0.00082	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NAT2—head and neck cancer	3.77e-05	0.000814	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—head and neck cancer	3.7e-05	0.0008	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—head and neck cancer	3.57e-05	0.000772	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—head and neck cancer	3.49e-05	0.000753	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DPYD—head and neck cancer	3.3e-05	0.000714	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—head and neck cancer	3.23e-05	0.000697	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—head and neck cancer	3.2e-05	0.00069	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—YAP1—head and neck cancer	3.14e-05	0.000677	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK3—head and neck cancer	3.05e-05	0.000659	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK1—head and neck cancer	2.9e-05	0.000627	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—head and neck cancer	2.9e-05	0.000627	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—head and neck cancer	2.52e-05	0.000544	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—head and neck cancer	2.44e-05	0.000527	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRAS—head and neck cancer	2.33e-05	0.000504	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.26e-05	0.000488	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—head and neck cancer	2.06e-05	0.000445	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—head and neck cancer	1.97e-05	0.000425	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TYMS—head and neck cancer	1.88e-05	0.000407	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.86e-05	0.000402	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—head and neck cancer	1.78e-05	0.000385	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.76e-05	0.000381	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.39e-05	0.0003	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—head and neck cancer	1.13e-05	0.000245	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.05e-05	0.000227	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—head and neck cancer	9.15e-06	0.000198	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.46e-06	0.000139	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—head and neck cancer	5.27e-06	0.000114	CbGpPWpGaD
